EUVIMEDEUVIMED entdecken
Crossref

ELABELA Protects Against Thoracic Aortic Dissection by Maintaining Vascular Smooth Muscle Cells Homeostasis and Regulating NETosis

Fen Zheng iD, Zhi Geng iD, Chao Ye iD, Mingyu Hao iD, Min Sha iD, Haoxuan Shan iD, Ying Zhou iD, Anyu Jiang iD, Wei Hou, Aidong Chen iD, Brain D Susan iD, Juejin Wang iD und 2 weitere

Arteriosclerosis, Thrombosis, and Vascular Biology · 2026

DOI: 10.1161/atvbaha.125.324169 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2026. Verfasst von Fen Zheng und 13 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine,…. Hauptthemen laut MEDLINE: Muscle, Smooth, Vascular, Myocytes, Smooth Muscle, Dissection, Thoracic Aorta, Aortic Dissection. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 47 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Thoracic aortic dissection (TAD) is a life-threatening aortic disease without effective medical treatment. Disruption of vascular smooth muscle cell (VSMC) homeostasis plays a vital role in triggering TAD. ELA (ELABELA) is a novel endogenous ligand for APJ (angiotensin receptor AT1–related receptor protein). However, the effects of ELA on TAD formation and development remain elusive. METHODS: Four-week-old C57BL/6J male mice were treated with β-aminopropionitrile monofumarate or β-aminopropionitrile monofumarate combined with Ang II (angiotensin II) to induce TAD models, and the aortic rupture occurred mainly in the descending thoracic region. ELA or saline was infused via osmotic minipumps into mice for 4 weeks. Transcriptomic studies and VSMC-derived conditioned medium were used to investigate the downstream molecular mechanisms of ELA. RESULTS: ELA infusion mitigated TAD development and prevented aortic media degradation in mice, which was reversed by APJ antagonist ML221. Exogenous ELA prevented the disruption of VSMC homeostasis under PDGF (platelet-derived growth factor) stimulation in VSMCs. Based on transcriptomic studies, we showed that ELA significantly inhibits NLRP3 (NLR family pyrin domain-containing 3)/IL (interleukin)-1β pathway activation and modulates NET (neutrophil extracellular trap) formation in vivo and in vitro. In human neutrophils, ELA significantly inhibited NETs’ formation, which is prevented by reactive oxidative species supplementation. Using VSMC-derived conditioned medium, we showed that NLRP3/IL-1β–related NETs’ formation connects cellular signaling from VSMCs to neutrophils, leading to disruption of VSMC homeostasis. Notably, ELA was downregulated in both plasma and aortic tissues of human TAD, and lower plasma ELA levels were associated with an increased risk of TAD. CONCLUSIONS: We provide evidence that ELA prevents TAD progression and aortic medial degeneration, primarily by maintaining VSMC homeostasis, which may be linked to the inhibition of NETosis in neutrophils and NLRP3/IL-1β–related cellular signaling between VSMCs and neutrophils. ELA shows promise as a target for pharmacological therapy and diagnostic TAD management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscle, Smooth, VascularMyocytes, Smooth MuscleDissection, Thoracic AortaAortic DissectionExtracellular TrapsAorta, ThoracicAortic Aneurysm, ThoracicAnimalsMaleMice, Inbred C57BLHomeostasisDisease Models, AnimalMiceNeutrophilsHumansSignal TransductionCells, CulturedNLR Family, Pyrin Domain-Containing 3 Protein

Stichwörter der Autor:innen

cardiovascular diseasesdissection, thoracic aortaextracellular trapsmuscle, smooth, vascularneutrophils

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinNlrp3 protein, mouse

Autor:innen und Institutionen

  • Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, and Department of Physiology (F.Z., M.H., H.S., Y.Z., A.J., W.H., A.C…
  • The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine (F.Z., M.S., J.W.), Nanjing Medical University, China.
  • Department of Cardiac Surgery, The Second Affiliated Hospital of Nanjing Medical University, China (Z.G., Q.L.).
  • Department of Basic Medicine, Wuxi School of Medicine, Jiangnan University, China (C.Y.).
  • Section of Vascular Biology & Inflammation, School of Cardiovascular and Metabolic Medicine & Sciences (South Bank), BHF Centre of Research Excellence, King's College London, United Kingdom (B.D.S.).

ORCID-Profile: Fen Zheng, Zhi Geng, Chao Ye, Mingyu Hao, Min Sha, Haoxuan Shan, Ying Zhou, Anyu Jiang, Aidong Chen, Brain D Susan, Juejin Wang, Qingguo Li, Xiaoqing Xiong

Zitieren

APA

Zheng, F., Geng, Z., Ye, C., Hao, M., Sha, M., Shan, H., Zhou, Y., Jiang, A., Hou, W., Chen, A., Susan, B. D., Wang, J., Li, Q., & Xiong, X. (2026). ELABELA Protects Against Thoracic Aortic Dissection by Maintaining Vascular Smooth Muscle Cells Homeostasis and Regulating NETosis. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.125.324169

Vancouver

Zheng F, Geng Z, Ye C, Hao M, Sha M, Shan H, et al. ELABELA Protects Against Thoracic Aortic Dissection by Maintaining Vascular Smooth Muscle Cells Homeostasis and Regulating NETosis. Arteriosclerosis, Thrombosis, and Vascular Biology. 2026. doi:10.1161/atvbaha.125.324169

BibTeX
@article{Zheng2026,
  author = {Zheng, Fen and Geng, Zhi and Ye, Chao and Hao, Mingyu and Sha, Min and Shan, Haoxuan and Zhou, Ying and Jiang, Anyu and Hou, Wei and Chen, Aidong and Susan, Brain D and Wang, Juejin and Li, Qingguo and Xiong, Xiaoqing},
  title = {ELABELA Protects Against Thoracic Aortic Dissection by Maintaining Vascular Smooth Muscle Cells Homeostasis and Regulating NETosis},
  journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
  year = {2026},
  doi = {10.1161/atvbaha.125.324169}
}
Kostenlos starten →